Fatty Acid and Protein Metabolism (1D) - Bio & Biochem

To probe protein catabolism during prolonged fasting, investigators measured urea nitrogen production in healthy adults before and after administration of a drug that inhibits hepatic transaminases (but does not affect renal clearance). Participants were kept on the same caloric restriction protocol throughout. Which outcome is most consistent with inhibiting transamination during fasting?
Answer: Decreased urea production because limiting amino group transfer reduces substrate flow into deamination and the urea cycle This question tests understanding of amino acid catabolism and urea cycle regulation during fasting. Transaminases catalyze the transfer of amino groups from amino acids to α-ketoglutarate, producing glutamate which can then be deaminated to release ammonia for urea synthesis. Inhibiting transaminases blocks this initial step of amino acid catabolism, reducing the flow of nitrogen into the urea cycle and decreasing urea production during protein breakdown in fasting. The correct answer D accurately describes this reduction in urea synthesis. Choice B incorrectly suggests transaminases consume ammonia, when they actually facilitate its eventual release through the glutamate dehydrogenase reaction. To trace nitrogen flow, follow amino groups from proteins through transamination to deamination to urea.
A nutrition study cultures human hepatocytes in media lacking an essential amino acid (leucine) for 12 hours, then measures global protein synthesis via incorporation of labeled methionine. Compared with complete media, leucine-depleted cells show decreased labeled methionine incorporation and increased phosphorylation of eIF2;1. Intracellular triglyceride content increases modestly. Which outcome is most consistent with these observations regarding fatty acid and protein metabolism?
Answer: Leucine depletion decreases global protein synthesis via stress signaling, which can reduce apolipoprotein production and favor intracellular triglyceride accumulation This question tests understanding of amino acid sensing, protein synthesis regulation, and its effects on lipid metabolism. Leucine is an essential amino acid that serves as a nutrient signal for protein synthesis through the mTOR pathway. Leucine depletion activates stress responses including phosphorylation of eIF2α, which globally decreases translation initiation and protein synthesis, as shown by reduced methionine incorporation. When protein synthesis decreases, hepatocytes produce fewer apolipoproteins needed for VLDL assembly and secretion, causing triglycerides to accumulate intracellularly rather than being exported. Choice A is incorrect because leucine depletion decreases, not increases, translation initiation through stress signaling pathways. When analyzing metabolic stress responses, consider how changes in one pathway (protein synthesis) can indirectly affect another (lipid export).
In adipose tissue explants, researchers compare the effects of insulin vs epinephrine on net release of non-esterified fatty acids (NEFAs) into the media over 20 minutes. Results (NEFA release, relative units): - Baseline: 1.0 - +Insulin: 0.6 - +Epinephrine: 1.8 What conclusion can be drawn about the role of insulin in fat storage?
Answer: Insulin counteracts lipolytic signaling, decreasing NEFA release and favoring triglyceride storage in adipose This question tests understanding of fatty acid metabolism, comparing insulin and epinephrine effects on adipose lipolysis. Insulin inhibits lipolysis, reducing non-esterified fatty acid (NEFA) release, while epinephrine activates it; this promotes storage versus mobilization. Results show decreased NEFA with insulin and increased with epinephrine, highlighting opposing roles. Choice D is correct as insulin counteracts lipolysis, favoring TAG storage. Choice B is incorrect because insulin and epinephrine have antagonistic, not synergistic, effects on lipase. In explant studies, measure release rates to quantify net lipolysis. Recall hormone signaling: insulin via PI3K, epinephrine via cAMP.
A purified mitochondrial acyl-CoA dehydrogenase is assayed at increasing concentrations of octanoyl-CoA. FAD reduction is monitored spectrophotometrically as a proxy for catalytic turnover. The enzyme is tested at pH 7.4 with excess electron acceptor present. Data (octanoyl-CoA, ;cM ;2 rate, AU/min): 5 ;2 0.10 10 ;2 0.18 20 ;2 0.30 40 ;2 0.39 80 ;2 0.44 Which outcome is most consistent with the data on enzyme activity?
Answer: The enzyme approaches a maximal rate at higher substrate, consistent with saturable active-site binding This question tests understanding of fatty acid metabolism, particularly enzyme kinetics in β-oxidation by acyl-CoA dehydrogenase. Acyl-CoA dehydrogenase catalyzes the first step of β-oxidation, dehydrogenating acyl-CoA in a saturable, Michaelis-Menten manner. The data show rate increasing but approaching a plateau at higher octanoyl-CoA, indicating saturation. Choice D is correct as it describes the enzyme reaching maximal rate due to active-site saturation. Choice C is incorrect because it claims the enzyme is unsaturable and regulated only by insulin, ignoring substrate-dependent kinetics. For kinetics analyses, fit data to hyperbolic curves and recall mitochondrial location doesn't preclude saturation. Distinguish between regulatory and kinetic controls in oxidation pathways.
A lab examines regulation of fatty acid entry into mitochondria in human cardiomyocytes. Cells are treated for 30 minutes with either vehicle or a compound that activates acetyl-CoA carboxylase (ACC), increasing malonyl-CoA. Palmitate oxidation is then measured as $^{14}$ CO $_2$ production from labeled palmitate under otherwise identical conditions. Based on the experimental setup, what is the most likely effect of ACC activation on metabolism?
Answer: Decreased palmitate oxidation because elevated malonyl-CoA inhibits CPT1, limiting mitochondrial entry of long-chain acyl-CoA This question tests understanding of malonyl-CoA's regulatory role in fatty acid metabolism. ACC catalyzes the formation of malonyl-CoA from acetyl-CoA, and malonyl-CoA serves as both the building block for fatty acid synthesis and a potent allosteric inhibitor of CPT1. By inhibiting CPT1, malonyl-CoA prevents long-chain acyl-CoA from being converted to acylcarnitine, blocking mitochondrial entry and subsequent beta-oxidation, thus reducing CO2 production from labeled palmitate. The correct answer B accurately describes this inhibitory effect on fatty acid oxidation. Choice A incorrectly states malonyl-CoA activates CPT1, when it is actually the key physiological inhibitor that coordinates the reciprocal regulation of fatty acid synthesis and oxidation. Remember that malonyl-CoA signals the fed state by simultaneously promoting synthesis and blocking oxidation.
A patient-derived hepatocyte line carries a loss-of-function mutation in carnitine palmitoyltransferase I (CPT1). Cells were cultured in low-glucose medium supplemented with palmitate-albumin for 12 hours. Compared with CRISPR-corrected isogenic controls, mutant cells showed: (i) lower oxygen consumption rate with palmitate, (ii) increased cytosolic long-chain acyl-CoA content, and (iii) unchanged oxygen consumption when provided octanoate (a medium-chain fatty acid). Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Answer: Reduced mitochondrial import of long-chain fatty acids, decreasing hepatic $\beta$ -oxidation during fasting conditions This question tests understanding of fatty acid metabolism compartmentalization and the role of CPT1 in mitochondrial fatty acid import. CPT1 is essential for converting long-chain acyl-CoAs (like palmitoyl-CoA) to acylcarnitines, enabling their transport into mitochondria for β-oxidation. Loss of CPT1 function prevents long-chain fatty acids from entering mitochondria, reducing hepatic β-oxidation especially during fasting when fatty acid oxidation normally provides energy and substrates for ketogenesis. The unchanged oxygen consumption with octanoate confirms that mitochondrial β-oxidation machinery is intact, as medium-chain fatty acids (8-10 carbons) can enter mitochondria directly without requiring the carnitine shuttle. Choice C is incorrect because β-oxidation occurs in mitochondria, not cytosol, and accumulated cytosolic acyl-CoA would inhibit, not increase, ketogenesis. When analyzing metabolic defects, consider whether the problem lies in substrate transport versus enzymatic catalysis by testing with substrates that bypass the suspected block.
A clinician suspects a defect in the hepatic urea cycle but notes the patient+cs symptoms worsen after prolonged fasting rather than high-protein intake. Plasma shows elevated FFAs, low ketones, and mild hyperammonemia. Genetic testing reveals a mutation in CPT2 (carnitine palmitoyltransferase II). Based on the experimental setup, what is the most likely link between the mutation and the observed hyperammonemia during fasting?
Answer: Reduced fatty acid oxidation lowers hepatic ATP availability, which can limit energetically costly nitrogen disposal pathways and exacerbate ammonia accumulation This question tests understanding of the intersection between fatty acid and protein metabolism, linking β-oxidation defects to urea cycle function via energy supply. CPT2 enables mitochondrial fatty acid entry for β-oxidation; its deficiency reduces hepatic ATP during fasting, impairing ATP-dependent urea synthesis and causing hyperammonemia. Symptoms worsen with fasting, with elevated FFAs, low ketones, and hyperammonemia, suggesting energy-limited urea cycle. Choice A is correct as reduced oxidation lowers ATP, limiting nitrogen disposal. Choice B is incorrect because CPT2 is involved in fatty acid transport, not direct urea catalysis. For crossover defects, consider how energy from one pathway supports another, like oxidation fueling ureagenesis. Evaluate fasting versus fed triggers to identify energetic dependencies.
A clinical trial tests an oral agent that partially inhibits hepatic mitochondrial beta-oxidation. After 1 week, fasting blood samples are collected. Compared with placebo, treated participants show higher plasma triglycerides and lower plasma ketones, without changes in dietary intake. Based on the experimental setup, what is the most likely effect of the intervention on metabolism?
Answer: Reduced generation of acetyl-CoA from fatty acids, decreasing ketogenesis and favoring re-esterification of fatty acids into triglycerides This question tests understanding of the relationship between hepatic beta-oxidation, ketogenesis, and triglyceride metabolism. Beta-oxidation in liver mitochondria generates acetyl-CoA, which during fasting is converted to ketone bodies for export to peripheral tissues. Inhibiting beta-oxidation reduces acetyl-CoA production, decreasing ketogenesis and causing fatty acids to accumulate and be re-esterified into triglycerides, which are packaged into VLDL and secreted, raising plasma triglycerides. The correct answer B accurately describes this metabolic redirection from oxidation to storage. Choice A incorrectly suggests increased ketogenesis when beta-oxidation is inhibited, which is impossible since beta-oxidation provides the acetyl-CoA substrate for ketone synthesis. When beta-oxidation is blocked, fatty acids must be stored rather than oxidized.
A clinical pharmacology group tested a new small molecule that activates adipose lipoprotein lipase (LPL) without directly affecting insulin secretion. Healthy volunteers received a single dose after a mixed meal. Two hours later, compared with placebo, plasma triglycerides were lower while plasma free fatty acids were not increased. What conclusion can be drawn about the role of insulin in fat storage, given these observations?
Answer: Lower triglycerides with unchanged free fatty acids is consistent with enhanced LPL-mediated uptake of fatty acids into adipose, a process typically promoted in the fed (insulin-high) state This question tests understanding of lipid metabolism regulation and the physiological role of lipoprotein lipase in the fed state. LPL hydrolyzes triglycerides in circulating lipoproteins (VLDL, chylomicrons) to release fatty acids for tissue uptake, particularly in adipose tissue where insulin normally activates LPL in the fed state. The drug's activation of adipose LPL mimics this insulin effect, enhancing fatty acid uptake from triglyceride-rich lipoproteins into adipocytes for storage, thereby lowering plasma triglycerides. The unchanged free fatty acid levels indicate efficient adipose uptake rather than simple hydrolysis with fatty acid release into circulation. Choice B is incorrect because LPL activation promotes, not prevents, fatty acid storage - if storage were blocked, free fatty acids would increase in plasma. This demonstrates how insulin coordinates postprandial lipid handling by activating adipose LPL to clear dietary triglycerides for storage.
Researchers investigated whether mitochondrial import limits long-chain fatty acid oxidation in human cardiac mitochondria. They measured initial oxygen consumption rates while varying carnitine concentration at fixed palmitoyl-CoA. In a parallel condition, they added excess octanoyl-CoA (which can enter mitochondria without the carnitine shuttle) to test whether downstream $;eta$ -oxidation capacity was intact. Which outcome is most consistent with the data on enzyme activity?
Answer: Low carnitine limits long-chain fatty acid oxidation by restricting acyl-group transport, while octanoyl-CoA partially rescues respiration This question tests understanding of fatty acid metabolism and the carnitine shuttle system's role in mitochondrial import. Carnitine is essential for transporting long-chain fatty acids into mitochondria by forming acylcarnitines via CPT1, which can then cross the inner membrane. Low carnitine availability limits this transport, restricting long-chain fatty acid oxidation despite intact β-oxidation machinery, as evidenced by the carnitine concentration-dependent oxygen consumption with palmitoyl-CoA. The partial rescue by octanoyl-CoA confirms that downstream β-oxidation capacity remains intact, as medium-chain fatty acids can enter mitochondria directly without requiring the carnitine shuttle. Choice A is incorrect because carnitine acts on transport, not on matrix enzyme activity - it doesn't allosterically regulate thiolase or other β-oxidation enzymes. When troubleshooting metabolic pathways, test with substrates that bypass suspected rate-limiting steps to distinguish transport limitations from enzymatic deficiencies.
A research team studies a patient-derived myocyte line with a suspected loss-of-function mutation in carnitine palmitoyltransferase I (CPT1). Cells are incubated with palmitate-albumin as the primary fuel, and oxygen consumption rate (OCR) is measured. OCR (pmol O2/min) is recorded under basal conditions and after addition of oligomycin (ATP synthase inhibitor) to estimate fatty-acid–supported respiration. Data: - Control cells: Basal OCR 160; +oligomycin 110 - CPT1-mutant cells: Basal OCR 95; +oligomycin 90 Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Answer: Reduced mitochondrial entry of long-chain fatty acids, decreasing $b2$ -oxidation and narrowing the oligomycin-sensitive OCR fraction This question tests understanding of fatty acid metabolism, specifically the role of carnitine palmitoyltransferase I (CPT1) in mitochondrial fatty acid transport. CPT1 facilitates the entry of long-chain fatty acids into mitochondria for β-oxidation by converting them to acylcarnitines. In the scenario, CPT1-mutant cells show reduced basal OCR and a smaller oligomycin-sensitive fraction compared to controls, indicating impaired fatty acid-supported respiration when palmitate is the fuel. Choice B is correct because the mutation reduces mitochondrial entry of long-chain fatty acids, decreasing β-oxidation and thus narrowing the oligomycin-sensitive OCR, which reflects ATP-linked respiration from fatty acids. Choice A is incorrect as it suggests increased mitochondrial import and ketone production, which contradicts the mutation's loss-of-function effect that blocks import. To reason through similar problems, identify the enzyme's role in the pathway and predict how its deficiency alters substrate flux and measurable outcomes like OCR. Additionally, compare data between mutant and control to quantify the metabolic shift.
In a short-term metabolic ward study, healthy volunteers receive either an insulin infusion (euglycemic clamp) or saline for 2 hours. Adipose microdialysis shows lower glycerol release with insulin, and plasma free fatty acids decrease. Skeletal muscle biopsies show increased malonyl-CoA levels with insulin. What conclusion can be drawn about the role of insulin in fat storage?
Answer: Insulin decreases fatty acid oxidation in muscle by increasing malonyl-CoA, which inhibits carnitine shuttle entry of long-chain acyl-CoA This question tests understanding of insulin's role in regulating fatty acid metabolism and the carnitine shuttle system. Insulin promotes anabolic processes and inhibits lipolysis in adipose tissue, as evidenced by decreased glycerol release (a marker of triglyceride breakdown). In muscle, insulin increases malonyl-CoA levels through activation of acetyl-CoA carboxylase (ACC), and malonyl-CoA is a potent inhibitor of carnitine palmitoyltransferase I (CPT1), the rate-limiting enzyme for fatty acid entry into mitochondria. By blocking CPT1, malonyl-CoA prevents long-chain acyl-CoA from entering mitochondria for β-oxidation, thereby decreasing fatty acid oxidation when glucose is available. Choice A is incorrect because insulin inhibits, not promotes, lipolysis by decreasing hormone-sensitive lipase activity. To solve similar problems, remember that insulin shifts metabolism toward storage and away from oxidation of fatty acids through multiple coordinated mechanisms.
A lab deprives cells of phenylalanine for 6 hours and measures secretion of a phenylalanine-rich plasma protein from hepatocytes. Intracellular mRNA levels for the protein are unchanged, but secreted protein decreases to 55% of control. Which interpretation best explains the data?
Answer: Amino acid limitation reduces translation efficiency for proteins requiring that amino acid, lowering output despite unchanged mRNA This question tests understanding of protein metabolism, focusing on phenylalanine deprivation's impact on secretion of phenylalanine-rich proteins. Deprivation limits translation of proteins requiring phenylalanine, reducing secretion without affecting mRNA levels. Decreased secreted protein despite stable mRNA indicates translational bottleneck. Choice A is correct because amino acid limitation reduces translation efficiency for dependent proteins. Choice C is incorrect as phenylalanine isn't required for transcription; effect is post-transcriptional. For secretion studies, compare mRNA and protein levels to localize effects. Note essential amino acids' roles in limiting synthesis of specific proteins.
To examine hormonal regulation of lipid storage, investigators infused healthy volunteers with either saline or insulin while maintaining euglycemia via glucose clamp. Subcutaneous adipose biopsies were taken after 2 hours to assess hormone-sensitive lipase (HSL) phosphorylation and plasma non-esterified fatty acids (NEFA). What conclusion can be drawn about the role of insulin in fat storage?
Answer: Insulin promotes fat storage by reducing HSL activation and lowering circulating NEFA This question tests understanding of insulin's role in regulating adipose tissue lipolysis. Insulin is the primary anabolic hormone that promotes fat storage by inhibiting hormone-sensitive lipase (HSL) through dephosphorylation, thereby reducing triglyceride breakdown and lowering plasma NEFA levels. The glucose clamp maintains constant blood glucose to isolate insulin's direct effects on lipid metabolism. The correct answer B accurately describes insulin's anti-lipolytic effect through HSL inhibition. Choice A incorrectly states insulin promotes lipolysis, which contradicts insulin's fundamental role as a storage hormone that opposes catabolism. When analyzing hormone effects, consider whether the hormone promotes anabolic (storage) or catabolic (breakdown) processes.
In a clamp study, healthy volunteers receive either a low-dose insulin infusion or saline while plasma glucose is maintained constant. Adipose biopsies are analyzed 60 minutes later for hormone-sensitive lipase (HSL) phosphorylation (Ser) and plasma is sampled for free fatty acids (FFAs). Observations: - Insulin group: decreased HSL phosphorylation; plasma FFA decreases by 45% - Saline group: no change in HSL phosphorylation; plasma FFA unchanged What conclusion can be drawn about the role of insulin in fat storage?
Answer: Insulin suppresses adipose triglyceride breakdown by reducing HSL activation, lowering circulating FFAs This question tests understanding of fatty acid metabolism, particularly insulin's regulation of lipolysis in adipose tissue. Insulin inhibits hormone-sensitive lipase (HSL) activation, reducing triglyceride breakdown and free fatty acid (FFA) release, promoting fat storage. In the clamp study, insulin decreases HSL phosphorylation and plasma FFAs, while saline shows no change, demonstrating insulin's antilipolytic effect. Choice B is correct as it accurately describes insulin suppressing adipose triglyceride breakdown by reducing HSL activation, lowering circulating FFAs. Choice A is incorrect because it states insulin promotes lipolysis, which is the opposite of its actual inhibitory role on HSL. To approach similar regulatory questions, recall hormone effects on key enzymes and correlate biochemical changes like phosphorylation with physiological outcomes like plasma metabolites. Verify by considering fasting versus fed states to contextualize insulin's actions.
A team assays a purified human glutamate dehydrogenase (GDH) preparation under two conditions: baseline and with a high concentration of ADP (an allosteric activator). They hold glutamate concentration constant and vary NAD $^+$ concentration. ADP increases the reaction rate at all NAD $^+$ concentrations and the curves approach a higher plateau than baseline. Which outcome is most consistent with the data on enzyme activity?
Answer: ADP increases the apparent $V_{max}$ , consistent with allosteric activation increasing catalytic activity of GDH This question tests understanding of allosteric regulation in protein metabolism, specifically glutamate dehydrogenase (GDH) regulation. GDH catalyzes the oxidative deamination of glutamate to α-ketoglutarate, linking amino acid and energy metabolism. ADP is a positive allosteric regulator of GDH that binds at a site distinct from the active site, inducing conformational changes that increase the enzyme's catalytic efficiency. The data shows that ADP increases reaction rates at all NAD+ concentrations and raises the maximum velocity plateau, characteristic of allosteric activation that increases Vmax without significantly affecting substrate binding affinity (Km). Choice C is incorrect because ADP is an allosteric activator binding at a regulatory site, not a competitive inhibitor at the NAD+ binding site. When analyzing allosteric regulation, look for changes in Vmax that indicate altered catalytic efficiency rather than just substrate binding.
In a study of human skeletal muscle homogenates, investigators measured carnitine palmitoyltransferase I (CPT1) activity by tracking formation of palmitoylcarnitine from palmitoyl-CoA. Reactions were run at fixed enzyme concentration with increasing palmitoyl-CoA, either without malonyl-CoA or with 10 µM malonyl-CoA (a physiologic inhibitor during the fed state). Initial rates were recorded over the first 60 seconds. Which outcome is most consistent with the data on enzyme activity?
Answer: Malonyl-CoA decreases the apparent affinity of CPT1 for palmitoyl-CoA, shifting the substrate–rate curve rightward without requiring a change in enzyme amount This question tests understanding of enzyme kinetics and regulation of fatty acid metabolism, specifically how malonyl-CoA inhibits CPT1. CPT1 catalyzes the rate-limiting step of fatty acid oxidation by converting fatty acyl-CoA to acylcarnitine for mitochondrial entry. Malonyl-CoA acts as a competitive inhibitor of CPT1, competing with palmitoyl-CoA for the active site, which increases the apparent Km (decreases affinity) without changing Vmax. The correct answer B accurately describes this competitive inhibition pattern where the substrate-rate curve shifts rightward. Choice A incorrectly suggests malonyl-CoA increases Vmax, which would indicate activation rather than inhibition. To identify competitive inhibition, look for increased Km with unchanged Vmax when inhibitor is present.
A lab models a branched-chain amino acid deficiency by culturing human hepatocytes in media lacking valine for 6 hours. Total protein synthesis is measured by incorporation of a labeled amino acid into newly synthesized proteins, while ATP levels are monitored and remain within 5% of baseline. Results: - Valine-replete media: protein synthesis index = 1.00 - Valine-free media: protein synthesis index = 0.52 Which interpretation best accounts for the observed change in protein synthesis?
Answer: Protein synthesis declines because ribosomes stall at valine codons and translation elongation cannot proceed efficiently This question tests understanding of protein metabolism, specifically how amino acid availability affects translation and protein synthesis. Protein synthesis requires all essential amino acids; deficiency in one, like valine, causes ribosomes to stall at codons for that amino acid, reducing overall translation efficiency. In valine-free media, protein synthesis decreases despite stable ATP, indicating the limitation is at the translational level rather than energy supply. Choice D is correct because ribosomes stall at valine codons, impeding elongation and lowering synthesis rates. Choice C is incorrect as it attributes the decline to halted oxidative phosphorylation, but ATP levels remain stable, ruling out energy depletion. For similar deficiency studies, assess whether the amino acid is essential and check energy status to differentiate translational from energetic effects. Consider measuring incorporation rates to quantify synthesis changes directly.
A newborn is diagnosed with primary carnitine deficiency due to impaired uptake of carnitine into cells. During an intercurrent illness with reduced oral intake, the infant develops lethargy. Laboratory testing shows low plasma ketones despite elevated free fatty acids. Based on the experimental setup, what is the most likely effect of the deficiency on metabolism?
Answer: Impaired transport of long-chain acyl groups into mitochondria, reducing beta-oxidation and ketone production during fasting This question tests understanding of carnitine's essential role in fatty acid oxidation. Carnitine is required for transporting long-chain fatty acyl groups across the inner mitochondrial membrane via the carnitine shuttle (CPT1 and CPT2 system). Without adequate carnitine, long-chain fatty acids cannot enter mitochondria for beta-oxidation, preventing acetyl-CoA generation and subsequent ketone body production during fasting, despite elevated free fatty acids in plasma. The correct answer A accurately describes this transport defect and its consequences. Choice B incorrectly places the defect in cytosolic transport, when the actual problem is mitochondrial entry for beta-oxidation. When evaluating metabolic defects, identify the specific transport or enzymatic step affected and trace the consequences.
An enzyme kinetics experiment measures initial velocity of glutamate dehydrogenase (GDH) in isolated human liver mitochondria while varying glutamate concentration; NAD+ is saturating. Ammonia production is quantified. Data (glutamate, mM ;2 v0, nmol NH3/min): 0.5 ;2 12 1.0 ;2 20 2.0 ;2 30 4.0 ;2 36 8.0 ;2 39 Which outcome is most consistent with the data on enzyme activity?
Answer: At high glutamate, GDH approaches a maximum rate, so additional glutamate produces diminishing increases in $v_0$ This question tests understanding of protein metabolism, focusing on kinetics of glutamate dehydrogenase (GDH) in amino acid catabolism. GDH catalyzes oxidative deamination of glutamate to α-ketoglutarate and ammonia, exhibiting saturable kinetics with respect to glutamate. The data show v0 increasing but plateauing at higher glutamate, consistent with Michaelis-Menten behavior. Choice D is correct as GDH approaches maximum rate at high substrate, yielding diminishing v0 increases. Choice B is incorrect because glutamate is the substrate, not product, so high levels drive forward reaction. For mitochondrial enzyme kinetics, ensure cofactors like NAD+ are saturating and monitor appropriate products. Recall GDH's role linking amino acid and carbohydrate metabolism.

Start this quiz